Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ricard Cervera

Showing results (71-80 of 412) with videos related to

Pageof 42
Sort By:
Best Practice & Research. Clinical Rheumatology|November 26, 2016
Catastrophic antiphospholipid syndrome: The current management approachIgnasi Rodriguez-Pintó, Gerard Espinosa, Ricard Cervera
Annals of the New York Academy of Sciences|September 26, 2007
Peripheral vascular occlusions leading to gangrene and amputations in antiphospholipid antibody positive patientsRonald A Asherson, Ricard Cervera, Yehuda Shoenfeld
The Journal of Rheumatology|September 6, 2007
Microangiopathic antiphospholipid-associated syndromes revisited new concepts relating to antiphospholipid antibodies and syndromesRonald A Asherson, Sylvia Pierangeli, Ricard Cervera
Current Rheumatology Reports|January 22, 2015
Catastrophic APS in the context of other thrombotic microangiopathiesIgnasi Rodríguez-Pintó, Gerard Espinosa, Ricard Cervera
Rheumatology (Oxford, England)|February 6, 2024
What we know and what we don't know about catastrophic antiphospholipid syndromeIgnasi Rodriguez-Pintó, Gerard Espinosa, Ricard Cervera
Expert Opinion on Drug Discovery|April 22, 2016
The problems and pitfalls in systemic lupus erythematosus drug discoveryIgnasi Rodríguez-Pintó, Gerard Espinosa, Ricard Cervera
Panminerva Medica|May 11, 2017
Catastrophic antiphospholipid syndrome: an updateGerard Espinosa, Ignasi Rodríguez-Pintó, Ricard Cervera
Autoimmunity Reviews|October 18, 2011
Facts and challenges for the autoimmunologist. Lessons from the second Colombian autoimmune symposiumJuan-Manuel Anaya, Yehuda Shoenfeld, Ricard Cervera
Lupus|October 21, 2020
Next stop in the treatment of refractory systemic lupus erythematosus: B-cell targeted combined therapyMargarida Matos Bela, Gerard Espinosa, Ricard Cervera
Frontiers in Immunology|September 28, 2020
Editorial: Primary Antiphospholipid SyndromeAntonio Serrano, Ricard Cervera, Jean Christophe Gris
Pageof 42

Showing results (71-80 of 412) with videos related to

Sort By:
Pageof 42
Best Practice & Research. Clinical Rheumatology|November 26, 2016
Catastrophic antiphospholipid syndrome: The current management approachIgnasi Rodriguez-Pintó, Gerard Espinosa, Ricard Cervera
Annals of the New York Academy of Sciences|September 26, 2007
Peripheral vascular occlusions leading to gangrene and amputations in antiphospholipid antibody positive patientsRonald A Asherson, Ricard Cervera, Yehuda Shoenfeld
The Journal of Rheumatology|September 6, 2007
Microangiopathic antiphospholipid-associated syndromes revisited new concepts relating to antiphospholipid antibodies and syndromesRonald A Asherson, Sylvia Pierangeli, Ricard Cervera
Current Rheumatology Reports|January 22, 2015
Catastrophic APS in the context of other thrombotic microangiopathiesIgnasi Rodríguez-Pintó, Gerard Espinosa, Ricard Cervera
Rheumatology (Oxford, England)|February 6, 2024
What we know and what we don't know about catastrophic antiphospholipid syndromeIgnasi Rodriguez-Pintó, Gerard Espinosa, Ricard Cervera
Expert Opinion on Drug Discovery|April 22, 2016
The problems and pitfalls in systemic lupus erythematosus drug discoveryIgnasi Rodríguez-Pintó, Gerard Espinosa, Ricard Cervera
Panminerva Medica|May 11, 2017
Catastrophic antiphospholipid syndrome: an updateGerard Espinosa, Ignasi Rodríguez-Pintó, Ricard Cervera
Autoimmunity Reviews|October 18, 2011
Facts and challenges for the autoimmunologist. Lessons from the second Colombian autoimmune symposiumJuan-Manuel Anaya, Yehuda Shoenfeld, Ricard Cervera
Lupus|October 21, 2020
Next stop in the treatment of refractory systemic lupus erythematosus: B-cell targeted combined therapyMargarida Matos Bela, Gerard Espinosa, Ricard Cervera
Frontiers in Immunology|September 28, 2020
Editorial: Primary Antiphospholipid SyndromeAntonio Serrano, Ricard Cervera, Jean Christophe Gris
Pageof 42